MediPharm Labs (MEDIF) Stock Price, News & Analysis

Company Overview

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products. MediPharm Labs also provides custom formulation and white-label manufacturing services to licensed producers and pharmaceutical partners, delivering turnkey solutions from initial concept through commercial production.

MediPharm Labs serves domestic clients across Canada’s provincial distribution networks and is advancing export opportunities in Europe and Latin America under evolving regulatory frameworks. Its operations emphasize consistent quality, rigorous testing, and strict adherence to international standards, positioning the company as a preferred partner for institutional and research-focused customers.

Founded in 2015 by Kully Saluja, who serves as President and CEO, MediPharm Labs has expanded its capacity through strategic investments in automation and analytics. The leadership team combines expertise in pharmaceutical manufacturing, regulatory compliance and cannabis science, guiding the company’s growth as it scales production and explores new markets.

Key Stats

• Today's Range: $0.06 to $0.06
• 50-Day Range: $0.05 to $0.07
• 52-Week Range: $0.04 to $0.08
• Volume: 203,107 shs
• Average Volume: 83,120 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MEDIF
• CIK: N/A
• Web: www.medipharmlabs.com
• Phone: (705) 719-7425
• Fax: N/A
• Employees: 166
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A